| Primary |
| Contraception |
40.2% |
| Menorrhagia |
16.3% |
| Endometriosis |
6.5% |
| Product Used For Unknown Indication |
6.5% |
| Dysmenorrhoea |
5.4% |
| Menstruation Irregular |
3.3% |
| Polycystic Ovaries |
3.3% |
| Depression |
2.2% |
| Hypertension |
2.2% |
| Ovarian Hyperstimulation Syndrome |
2.2% |
| Premenstrual Syndrome |
2.2% |
| Amenorrhoea |
1.1% |
| Malaria Prophylaxis |
1.1% |
| Menstrual Cycle Management |
1.1% |
| Metrorrhagia |
1.1% |
| Obesity |
1.1% |
| Ovarian Neoplasm |
1.1% |
| Premature Menopause |
1.1% |
| Preoperative Care |
1.1% |
| Uterine Leiomyoma |
1.1% |
|
| Pulmonary Embolism |
30.2% |
| Thrombosis |
9.4% |
| Respiratory Arrest |
5.7% |
| Respiratory Failure |
5.7% |
| Cerebral Venous Thrombosis |
3.8% |
| Convulsion |
3.8% |
| Palpitations |
3.8% |
| Thoracic Outlet Syndrome |
3.8% |
| Thrombophlebitis Superficial |
3.8% |
| Transient Ischaemic Attack |
3.8% |
| Urine Output Decreased |
3.8% |
| Uterine Leiomyoma |
3.8% |
| Venous Thrombosis Limb |
3.8% |
| Weight Decreased |
3.8% |
| Arterial Thrombosis |
1.9% |
| Cerebral Haemorrhage |
1.9% |
| Coeliac Disease |
1.9% |
| Coma |
1.9% |
| Embolism Venous |
1.9% |
| Glomerulonephritis Chronic |
1.9% |
|
| Secondary |
| Contraception |
25.5% |
| Menorrhagia |
10.6% |
| Depression |
8.5% |
| Drug Use For Unknown Indication |
8.5% |
| Product Used For Unknown Indication |
6.4% |
| Menstruation Irregular |
4.3% |
| Oedema |
4.3% |
| Ovarian Disorder |
4.3% |
| Ovarian Hyperfunction |
4.3% |
| Ovarian Hyperstimulation Syndrome |
4.3% |
| Superovulation |
4.3% |
| Hypertension |
2.1% |
| Metrorrhagia |
2.1% |
| Obesity |
2.1% |
| Onychomycosis |
2.1% |
| Oral Contraception |
2.1% |
| Ovulation Induction |
2.1% |
| Uterine Leiomyoma |
2.1% |
|
| Ovarian Hyperstimulation Syndrome |
10.0% |
| Pregnancy On Oral Contraceptive |
10.0% |
| Pulmonary Embolism |
10.0% |
| Ectopic Pregnancy |
5.0% |
| Hereditary Angioedema |
5.0% |
| Leukocytoclastic Vasculitis |
5.0% |
| Metrorrhagia |
5.0% |
| Photophobia |
5.0% |
| Rectal Tenesmus |
5.0% |
| Respiratory Disorder |
5.0% |
| Skin Discolouration |
5.0% |
| Thrombosis |
5.0% |
| Unintended Pregnancy |
5.0% |
| Urticaria |
5.0% |
| Uterine Dilation And Curettage |
5.0% |
| Vomiting |
5.0% |
| Weight Decreased |
5.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
33.8% |
| Crohn's Disease |
10.1% |
| Rheumatoid Arthritis |
8.8% |
| Contraception |
8.3% |
| Product Used For Unknown Indication |
7.0% |
| Psoriasis |
6.1% |
| Depression |
4.4% |
| Fibromyalgia |
2.2% |
| Oral Contraception |
2.2% |
| Pain |
2.2% |
| Accidental Exposure |
1.8% |
| Blood Corticotrophin Decreased |
1.8% |
| Blood Thyroid Stimulating Hormone Decreased |
1.8% |
| Depressive Disorder |
1.8% |
| Bipolar Disorder |
1.3% |
| Blood Antidiuretic Hormone Decreased |
1.3% |
| Blood Follicle Stimulating Hormone Decreased |
1.3% |
| Blood Luteinising Hormone Decreased |
1.3% |
| Hypogonadism Female |
1.3% |
| Hypothyroidism |
1.3% |
|
| Weight Increased |
10.4% |
| Paraesthesia |
8.3% |
| Unintended Pregnancy |
8.3% |
| Diarrhoea |
6.3% |
| Injection Site Pain |
6.3% |
| Pain In Extremity |
6.3% |
| Pneumonia |
6.3% |
| Weight Decreased |
6.3% |
| Accidental Exposure |
4.2% |
| Hyponatraemia |
4.2% |
| Injection Site Irritation |
4.2% |
| Mania |
4.2% |
| Nervousness |
4.2% |
| Ovarian Cyst Ruptured |
4.2% |
| Withdrawal Syndrome |
4.2% |
| Wrong Technique In Drug Usage Process |
4.2% |
| Colour Blindness |
2.1% |
| Complication Of Pregnancy |
2.1% |
| Device Breakage |
2.1% |
| Drug Delivery System Malfunction |
2.1% |
|
